These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
166 related articles for article (PubMed ID: 11168803)
21. CD44 and RHAMM are essential for rapid growth of bladder cancer driven by loss of Glycogen Debranching Enzyme (AGL). Oldenburg D; Ru Y; Weinhaus B; Cash S; Theodorescu D; Guin S BMC Cancer; 2016 Sep; 16(1):713. PubMed ID: 27595989 [TBL] [Abstract][Full Text] [Related]
22. Acute lung injury fibroblast migration and invasion of a fibrin matrix is mediated by CD44. Svee K; White J; Vaillant P; Jessurun J; Roongta U; Krumwiede M; Johnson D; Henke C J Clin Invest; 1996 Oct; 98(8):1713-27. PubMed ID: 8878421 [TBL] [Abstract][Full Text] [Related]
23. The intracellular hyaluronan receptor RHAMM/IHABP interacts with microtubules and actin filaments. Assmann V; Jenkinson D; Marshall JF; Hart IR J Cell Sci; 1999 Nov; 112 ( Pt 22)():3943-54. PubMed ID: 10547355 [TBL] [Abstract][Full Text] [Related]
24. Recombinant CD44-HABD is a novel and potent direct angiogenesis inhibitor enforcing endothelial cell-specific growth inhibition independently of hyaluronic acid binding. Päll T; Gad A; Kasak L; Drews M; Strömblad S; Kogerman P Oncogene; 2004 Oct; 23(47):7874-81. PubMed ID: 15361838 [TBL] [Abstract][Full Text] [Related]
25. A new polyclonal antibody that recognizes a human receptor for hyaluronan mediated motility. Kuwabara H; Yoneda M; Nagai M; Hayasaki H; Mori H Cancer Lett; 2004 Jul; 210(1):73-80. PubMed ID: 15172123 [TBL] [Abstract][Full Text] [Related]
26. Characterisation of the murine gene encoding the intracellular hyaluronan receptor IHABP (RHAMM). Fieber C; Plug R; Sleeman J; Dall P; Ponta H; Hofmann M Gene; 1999 Jan; 226(1):41-50. PubMed ID: 9889313 [TBL] [Abstract][Full Text] [Related]
27. Ras-transformed cells express both CD44 and RHAMM hyaluronan receptors: only RHAMM is essential for hyaluronan-promoted locomotion. Turley EA; Austen L; Moore D; Hoare K Exp Cell Res; 1993 Aug; 207(2):277-82. PubMed ID: 7688314 [TBL] [Abstract][Full Text] [Related]
28. Receptor for hyaluronic acid-mediated motility (RHAMM, CD168) expression is prognostically important in both nodal negative and nodal positive large cell lung cancer. Augustin F; Fiegl M; Schmid T; Pomme G; Sterlacci W; Tzankov A J Clin Pathol; 2015 May; 68(5):368-73. PubMed ID: 25731190 [TBL] [Abstract][Full Text] [Related]
29. Migration of highly aggressive melanoma cells on hyaluronic acid is associated with functional changes, increased turnover and shedding of CD44 receptors. Goebeler M; Kaufmann D; Bröcker EB; Klein CE J Cell Sci; 1996 Jul; 109 ( Pt 7)():1957-64. PubMed ID: 8832418 [TBL] [Abstract][Full Text] [Related]
30. Hyaluronan-dependent motility of B cells and leukemic plasma cells in blood, but not of bone marrow plasma cells, in multiple myeloma: alternate use of receptor for hyaluronan-mediated motility (RHAMM) and CD44. Masellis-Smith A; Belch AR; Mant MJ; Turley EA; Pilarski LM Blood; 1996 Mar; 87(5):1891-9. PubMed ID: 8634437 [TBL] [Abstract][Full Text] [Related]
31. Hyaluronic acid enhances cell proliferation during eosinopoiesis through the CD44 surface antigen. Hamann KJ; Dowling TL; Neeley SP; Grant JA; Leff AR J Immunol; 1995 Apr; 154(8):4073-80. PubMed ID: 7535820 [TBL] [Abstract][Full Text] [Related]
32. Expression and role of the hyaluronan receptor RHAMM in inflammation after bleomycin injury. Zaman A; Cui Z; Foley JP; Zhao H; Grimm PC; Delisser HM; Savani RC Am J Respir Cell Mol Biol; 2005 Nov; 33(5):447-54. PubMed ID: 16037485 [TBL] [Abstract][Full Text] [Related]
33. Hyaluronan increases RANKL expression in bone marrow stromal cells through CD44. Cao JJ; Singleton PA; Majumdar S; Boudignon B; Burghardt A; Kurimoto P; Wronski TJ; Bourguignon LY; Halloran BP J Bone Miner Res; 2005 Jan; 20(1):30-40. PubMed ID: 15619667 [TBL] [Abstract][Full Text] [Related]
34. Involvement of CD44 variant isoforms in hyaluronate adhesion by human activated T cells. Galluzzo E; Albi N; Fiorucci S; Merigiola C; Ruggeri L; Tosti A; Grossi CE; Velardi A Eur J Immunol; 1995 Oct; 25(10):2932-9. PubMed ID: 7589094 [TBL] [Abstract][Full Text] [Related]
35. Hyaluronic acid synthase-1 expression regulates bladder cancer growth, invasion, and angiogenesis through CD44. Golshani R; Lopez L; Estrella V; Kramer M; Iida N; Lokeshwar VB Cancer Res; 2008 Jan; 68(2):483-91. PubMed ID: 18199543 [TBL] [Abstract][Full Text] [Related]
36. Regulated expression of a receptor for hyaluronan-mediated motility on human thymocytes and T cells. Pilarski LM; Miszta H; Turley EA J Immunol; 1993 May; 150(10):4292-302. PubMed ID: 7683315 [TBL] [Abstract][Full Text] [Related]
37. Induction of posterior capsule opacification by hyaluronic acid in an ex vivo model. Chandler HL; Haeussler DJ; Gemensky-Metzler AJ; Wilkie DA; Lutz EA Invest Ophthalmol Vis Sci; 2012 Apr; 53(4):1835-45. PubMed ID: 22408013 [TBL] [Abstract][Full Text] [Related]
38. A peptide with three hyaluronan binding motifs inhibits tumor growth and induces apoptosis. Xu XM; Chen Y; Chen J; Yang S; Gao F; Underhill CB; Creswell K; Zhang L Cancer Res; 2003 Sep; 63(18):5685-90. PubMed ID: 14522884 [TBL] [Abstract][Full Text] [Related]
39. Differential expression of CD44 in canine melanocytic tumours. Serra M; Rabanal RM; Miquel L; Domenzain C; Bassols A J Comp Pathol; 2004; 130(2-3):171-80. PubMed ID: 15003475 [TBL] [Abstract][Full Text] [Related]
40. [Characteristics of expression of CD44v and receptor for HA-mediated motility (RHAMM) in multi-step gastrocarcinogenesis]. Li H; Li J; Guo L Zhonghua Zhong Liu Za Zhi; 1999 Sep; 21(5):329-31. PubMed ID: 11776566 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]